COVID-19 Effect – The Ultrasound Probe Disinfection Market Gets Moving

Posted in Medical Devices by Adolf on Oct 25,2021 905

As the technology advances each day, there have been numerous changes happening in the medical and health sector. However, one thing that remains constant is that people with any medical issues visit their doctors to be analysed and treated. At times it may seem as a simple matter like a common cold or fever, but with the complications arising due to the current pandemic, it can prove fatal if not treated properly.

Recognized as one of the simplest and safest diagnostics in the healthcare market, an ultrasound probe device creates images so that the internal body organs can be examined. The machine makes sound waves that rebounds off the body tissues and makes echoes. These echoes are then transferred to the computer to generate images called sonograms. The ultrasound tests, also known as sonography are performed by a sonographer or an ultrasound technician, post which the doctor checks the results and helps to identify the problem within the body.

The Ultrasound Probe Disinfection Market

Ultrasound probe machines are used to detect and treat various medical conditions including pregnancy, wellness of the heart, liver, bladder, kidneys, uterus, ovaries, eyes and thyroid among others. Further enhancements in the ultrasound procedures have helped improve diagnosis by getting instant health information. Moreover, it is painless, requires no injections, it is generally accessible and less expensive. Also the patients are not exposed to any harmful radiations that are emitted from X-rays or CT scans.

Ultrasound Probe Disinfection Matters

Keeping the ultrasound probe clean and disinfected is very important. While normal cleaning can remove visible dirt particles, a high-level disinfection would be required to eliminate harmful infection causing germs. Also, there is an increase in professional awareness on the ultrasound probe disinfection, as the use of unclean devices can lead to serious infections in the patient or cause malfunctioning of the instrument. 

Due to the outbreaks of several infections in recent years, there has been escalating number of cases related to chronic diseases with the growing prevalence of cardiovascular and neurological ailments, gastrointestinal disorders and ever growing geriatric population. Many companies are investing heavily in incorporating advanced sterilization technologies in order to offer high quality, latest sterilization technologies service to hospitals with growing transmission of coronavirus across the world.

High demand for sterilization equipment from pharmaceutical industry in order to ensure the efficacy of the final drug product has been a key factor behind its massive share in the market. Growing prevalence of healthcare associated infections globally, has been boosting the demand for sterilization equipment in hospitals. Also, persistent threat of Covid-19 will be driving the pharmaceuticals companies to develop effective sterilizers. Hospitals and pharmaceutical manufacturing, has been forecasted to supplement the market growth in the coming years.

The global ultrasound probe disinfection market is projected to reach US$ 809 million by 2026 from US$ 443 million in 2021, at a CAGR of 12.8% during the forecast period. Market growth is largely driven by the increasing number of ultrasound imaging procedures, the rising incidence of hospital-acquired infections due to improper reprocessing of ultrasound probes, the increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, government regulations and guidelines in developed markets, and technological advancements in ultrasound probes. However, the high cost of automated probe re-processors and reluctance to shift from manual disinfection methods to automated probe re-processors are restraining the growth of this market. Some of the challenges faced by the market are due to lack of knowledge about reprocessing and inadequate cleaning and disinfection of probes.

According to the medical device market research, the increasing demand for high-level disinfectants for critical and semi-critical ultrasound probes, the ease of handling of consumables such as disinfectant wipes, and the relatively smaller capital investment required to adopt consumables for disinfection in hospitals and diagnostic imaging centres drives the growth of this segment. Also, the increasing awareness of HAIs, growing number of ultrasound imaging procedures during surgeries, growing regulatory norms for disinfection, and the increasing demand for automated disinfection systems for the high-level disinfection of TEE and endocavitary transducers are the key factors driving the demand for the high-level disinfection process.

Key players in the Ultrasound probe disinfection market include Nanosonics (Australia), Tristel (UK), STERIS (UK), and Ecolab (US), Advanced Sterilization Products (US), CIVCO Medical Solutions (US), CS Medical LLC (US), Virox Technologies Inc. (Canada), Germitec S. A. (France). Other players include Schülke & Mayr GmbH (Germany), Parker Laboratories Inc. (US), Metrex Research LLC (US), Soluscope SA (France), Dr. Schumacher GmbH (Germany), Whiteley Medical (New Zealand), MMM Group (Germany), GAMA Healthcare Ltd. (UK), Ruhof Corporation (US), BODE Chemie GmbH (Germany), PDI (US), Advanced Ultrasound Solutions Inc. (US), IMA-X (Luxembourg), Diversey Holdings (US), Borer Chemie AG (Switzerland), and Medevice Healthtech (India).

The hospitals & diagnostic imaging centres segment accounted for the highest rate of the ultrasound probe disinfection market in 2020. The largest share of this segment can primarily be attributed to the increasing number of ultrasound imaging procedures performed and the growing demand for the high-level disinfection of critical and semi-critical ultrasound probes used in ambulatory care centres.


Comment / Reply From